Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Molecular Therapy. Oncology|February 6, 2026
Current use of pre-clinical models for evaluation of human adenovirus-based cancer therapeuticsDavid K Cole, Rahul C Khanolkar, James A Davies, et al.
Science Advances|September 14, 2019
Human adenovirus type 26 uses sialic acid-bearing glycans as a primary cell entry receptorAlexander T Baker, Rosie M Mundy, James A Davies, et al.
Viruses|May 27, 2023
Engineering Adenoviral Vectors with Improved GBM SelectivityEmily A Bates, Charlotte Lovatt, Alice R Plein, et al.
Scientific Reports|September 8, 2019
Systemic delivery and SPECT/CT in vivo imaging of <sup>125</sup>I-labelled oncolytic adenoviral mutants in models of pancreatic cancerY K Stella Man, Julie Foster, Elisabete Carapuça, et al.
Oncotarget|June 15, 2018
Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirusSarah L Hulin-Curtis, James A Davies, Rachel Jones, et al.
Molecular Cancer Therapeutics|January 26, 2018
The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer CellsY K Stella Man, James A Davies, Lynda Coughlan, et al.
Nature Communications|February 16, 2019
Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactionsAlexander T Baker, Alexander Greenshields-Watson, Lynda Coughlan, et al.
British Journal of Cancer|October 5, 2024
The αvβ6 integrin specific virotherapy, Ad5<sub>NULL</sub>-A20.FCU1, selectively delivers potent "in-tumour" chemotherapy to pancreatic ductal adenocarcinomaLuned M Badder, James A Davies, Valerie S Meniel, et al.
Immunology|February 27, 2021
Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicityAlicia Teijeira Crespo, Stephanie Burnell, Lorenzo Capitani, et al.
Viruses|June 2, 2021
Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5<sub>NULL</sub>-A20James A Davies, Gareth Marlow, Hanni K Uusi-Kerttula, et al.
Pageof 3